UMB Financial Reports Strong Q1 Earnings Beat, Raises Dividend, and Boosts Share Repurchase Program
summarizeSummary
UMB Financial reported a significant Q1 earnings beat with strong financial growth, increased its common stock dividend, and authorized a substantial share repurchase program.
check_boxKey Events
-
Exceeded Q1 Earnings Estimates
Reported Q1 adjusted earnings per share of $4.76, significantly beating the IBES estimate of $2.80, alongside a 222.3% increase in GAAP net income available to common shareholders year-over-year.
-
Strong Financial Performance
Achieved 31.1% year-over-year revenue growth to $739.2 million and a 34.4% increase in net interest income to $534.4 million, with net interest margin expanding by 42 basis points.
-
Increased Common Stock Dividend
Declared a quarterly common stock dividend of $0.43 per share, an increase from the previous $0.40 per share, payable on July 1, 2026.
-
Expanded Share Repurchase Authorization
The Board authorized the repurchase of up to 2 million shares of common stock, representing approximately 2.6% of outstanding shares, signaling a strong commitment to capital return.
auto_awesomeAnalysis
UMB Financial Corporation delivered exceptional first-quarter results, significantly surpassing analyst expectations with adjusted earnings per share of $4.76 against an estimated $2.80. This strong performance was driven by substantial year-over-year growth in net income, revenue, and net interest income, alongside an improved efficiency ratio and healthy loan and deposit expansion. Further demonstrating confidence, the Board of Directors increased the quarterly common stock dividend to $0.43 per share and authorized a new share repurchase program for up to 2 million shares, representing approximately 2.6% of outstanding common stock. This comprehensive positive update signals robust operational health and a commitment to shareholder returns.
At the time of this filing, UMBF was trading at $125.15 on NASDAQ in the Finance sector, with a market capitalization of approximately $9.5B. The 52-week trading range was $90.96 to $136.11. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.